Retrospective Study
Copyright ©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Oncol. Jun 15, 2024; 16(6): 2429-2438
Published online Jun 15, 2024. doi: 10.4251/wjgo.v16.i6.2429
Predictive value of preoperative routine examination for the prognosis of patients with pT2N0M0 or pT3N0M0 colorectal cancer
Peng-Fei Jing, Jin Chen, En-Da Yu, Chao-Yu Miao
Peng-Fei Jing, En-Da Yu, Department of Colorectal Surgery, Changhai Hospital, Second Military Medical University/Naval Medical University, Shanghai 200433, China
Jin Chen, Department of Endocrinology and Metabolism, Changhai Hospital, Second Military Medical University/Naval Medical University, Shanghai 200433, China
Chao-Yu Miao, Department of Pharmacology, Second Military Medical University/Naval Medical University, Shanghai 200433, China
Co-corresponding authors: En-Da Yu and Chao-Yu Miao.
Author contributions: Yu ED and Miao CY performed study concept and design, revised the manuscript and made final approval of the version; Jing PF participated in collection and assembly of data; Jing PF and Chen J analyzed data and wrote the manuscript; and all authors read and approved the final paper.
Institutional review board statement: Our study complies with all ethical regulations of the Changhai Hospital Ethics Committee, and granted the ethical number: CHEC2023-125.
Informed consent statement: All study participants, or their legal guardian, provided informed written consent prior to study enrollment.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Data sharing statement: All data generated or analyzed during this study are included in this paper, and further inquiries can be directed to the corresponding author (endayuchanghai@smmu.edu.cn).
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Chao-Yu Miao, Professor, Department of Pharmacology, Second Military Medical University/Naval Medical University, No. 325 Guohe Road, Shanghai 200433, China. cymiao@smmu.edu.cn
Received: November 24, 2023
Revised: March 3, 2024
Accepted: April 9, 2024
Published online: June 15, 2024
Processing time: 203 Days and 16.8 Hours
Core Tip

Core Tip: By analyzing the results of preoperative blood tests for pT2N0M0/pT3N0M0, we found that preoperative platelet count was a protective factor for disease-free survival, while serum carcinoembryonic antigen level was an independent risk factor for overall survival. Given that these measures are easier to detect and more widely available, they may have a broader application in the future.